Physician profile
Ragheed Alturkmani
NPI 1497947220
$8,148.82
in general payments reported to CMS, 2019-2025
57 companies · $2,036 in 2025
The $2,036 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,744 · 2020: $262 · 2021: $191 · 2022: $552 · 2023: $1,441 · 2024: $1,923 · 2025: $2,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,099 · Travel and Lodging: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,099.19 |
| Travel and Lodging | $300.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $1,317.89 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Glaxosmithkline, LLC. | $982.19 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $624.08 | 2019-2025 | Tezspire, Tagrisso, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $595.33 | 2019-2025 | Ofev, Jascayd |
| Coaptech, INC. | $518.86 | 2024-2025 | Puma System, Puma System |
| Regeneron Healthcare Solutions, INC. | $366.78 | 2023-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $352.31 | 2019-2025 | |
| Grifols USA, LLC | $273.00 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $228.63 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $196.77 | 2019-2025 | Keytruda, Lynparza |
| Actelion Pharmaceuticals US, INC. | $166.60 | 2021-2025 | Uptravi, Opsumit |
| Mallinckrodt Hospital Products INC. | $161.75 | 2020-2025 | Acthar |
| Galvanize Therapeutics, INC | $149.27 | 2023 | Aliya System |
| Ani Pharmaceuticals, INC. | $135.68 | 2024-2025 | Purified Cortrophin Gel |
| Csa Medical, INC | $133.57 | 2019 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $126.83 | 2023-2025 | Zoladex, Xermelo |
| Jazz Pharmaceuticals INC. | $118.56 | 2022-2025 | |
| Seagen INC. | $116.70 | 2020-2023 | Tukysa, Adcetris, Tivdak |
| Daiichi Sankyo INC. | $110.79 | 2022-2024 | Enhertu |
| Insmed, INC. | $103.87 | 2022-2025 | Arikayce |
| Sunovion Pharmaceuticals INC. | $102.50 | 2019-2020 | |
| Mylan Specialty L.P. | $101.92 | 2019-2024 | Yupelri |
| Mallinckrodt Enterprises LLC | $101.59 | 2019 | |
| Verona Pharma, INC. | $88.73 | 2025 | Ohtuvayre |
| Baxter Healthcare | $80.62 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $65.07 | 2025 | Yupelri |
| Janssen Biotech, INC. | $56.05 | 2022-2025 | Rybrevant |
| Stemline Therapeutics INC. | $48.77 | 2023-2024 | Elzonris, Orserdu |
| Avadel Cns Pharmaceuticals, LLC | $48.76 | 2024-2025 | Lumryz |
| Exelixis INC. | $45.02 | 2024 | Cabometyx |
| Pfizer INC. | $41.91 | 2022-2024 | |
| Karyopharm Therapeutics INC. | $41.83 | 2024 | Xpovio |
| La Jolla Pharmaceutical Company | $38.64 | 2023-2025 | Giapreza |
| Boston Scientific Corporation | $34.87 | 2025 | Varithena Administration Pack |
| Morphosys, US INC. | $34.54 | 2022 | |
| Abbvie INC. | $28.50 | 2023 | Dalvance |
| Lilly USA, LLC | $27.00 | 2025 | Zepbound |
| Genentech USA, INC. | $25.92 | 2024 | Alecensa, Tecentriq, Gavreto |
| Harmony Biosciences LLC | $25.70 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.56 | 2023 | Iclusig |
| Electromed, INC. | $21.83 | 2022 | |
| United Therapeutics Corporation | $21.66 | 2021 | |
| Philips North America LLC | $19.52 | 2024 | (Ak6) Vest Therapy |
| Bard Peripheral Vascular, INC. | $18.95 | 2023 | |
| Inari Medical, INC. | $18.85 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| G1 Therapeutics, INC. | $18.76 | 2023 | Cosela |
| Adaptive Biotechnologies Corporation | $18.17 | 2024 | Clonoseq |
| Incyte Corporation | $18.11 | 2024 | Monjuvi |
| E.R. Squibb & Sons, L.L.C. | $17.89 | 2024 | Opdivo |
| Teva Pharmaceuticals USA, INC. | $17.84 | 2020 | |
| Allergan, INC. | $17.75 | 2020 | |
| Veran Medical Technologies, INC. | $17.35 | 2020 | |
| Intuitive Surgical, INC. | $16.99 | 2022 | |
| Genmab U.S., INC. | $16.98 | 2024 | Epkinly |
| Novartis Pharmaceuticals Corporation | $16.74 | 2025 | |
| Olympus America INC. | $16.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ragheed Alturkmani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.